- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01794832
Severe Aortic Stenosis in Patients Referred for Valve Surgery (SAS)
April 2, 2014 updated by: Amjad Iqbal Hussain, Oslo University Hospital
A Prospective Longitudinal Study of Severe Aortic Stenosis in Elderly and Outcome of Aortic Surgery.
Our main hypothesis on the present study is that new parameters such as risk-taking behavior, patients motivation, health related quality of life, new biomarkers and more precise echocardiography measures in addition to traditional parameters will improve pre-operative risk assessment in patients with AS and better guide patients and doctors in decision whether to operate or not.
Study Overview
Status
Unknown
Detailed Description
Patients referred for surgery are included thorough reading referral letter. Data collected in the study wil be compared with data from Medical records and clinical examination.
Data entered will be controlled by two investigators.
Data wil be compared to national norms and from result of other studies.
Study Type
Observational
Enrollment (Anticipated)
500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Oslo, Norway
- Recruiting
- Oslo University hospital- Rikshospitalet
-
Contact:
- Lars Gullestad, professor
- Email: lars.gullestad@medisin.uio.no
-
Principal Investigator:
- Amjad Iqbal Hussain
-
Principal Investigator:
- Andreas Auensen, Md
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Inclusion: Patients above 18 years with symptomatic AS referred to preoperative examination will be included.
Patients will undergo standard investigations with regard to assessment of the clinical indication for operation
Description
Inclusion Criteria:
- Patients above 18 years with symptomatic AS referred to preoperative examination.
Exclusion Criteria:
- Exclusion: Patients who do not want to participate. Patients not able to speak and read Norwegian.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Elderly with severe aortic stenosis
Patients with severe symptomatic aortic stenosis referred for consideration of surgical aortic valve replacement
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Death due cardiovascular events
Time Frame: one year
|
one year
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
MACE ( Major cardiovascular events )
Time Frame: 30 days
|
Cerebral complications (stroke/bleeding), bleeding, renal failure, arrythmias, needs for pacemaker, prolong ICU stay, wound infections
|
30 days
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in Health related Quality and function one year after inclusion
Time Frame: one year
|
Patients in the study perform Short Form-36, EuroQual-5D at inclusion and one year after.
We want to compare the result of their scoring to obtain the gain in HRQoL of the intervention
|
one year
|
|
Hospital visit and use of Health services last years
Time Frame: 30 days
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Kjell I Pettersen, MD, University of Oslo
- Principal Investigator: Amjad I Hussain, MD, Oslo University Hosptial
- Study Chair: Lars Gullestad, Professor, Oslo University Hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Arain F, Abraityte A, Bogdanova M, Solberg OG, Michelsen AE, Lekva T, Aakhus S, Holm S, Halvorsen B, Finsen AV, Vinge LE, Nymo S, Espeland T, Ranheim T, Aukrust P, Vaage IJ, Auensen A, Gullestad L, Ueland T. YKL-40 (Chitinase-3-Like Protein 1) Serum Levels in Aortic Stenosis. Circ Heart Fail. 2020 Oct;13(10):e006643. doi: 10.1161/CIRCHEARTFAILURE.119.006643. Epub 2020 Sep 23.
- Kvaslerud AB, Hussain AI, Auensen A, Ueland T, Michelsen AE, Pettersen KI, Aukrust P, Morkrid L, Gullestad L, Broch K. Prevalence and prognostic implication of iron deficiency and anaemia in patients with severe aortic stenosis. Open Heart. 2018 Dec 16;5(2):e000901. doi: 10.1136/openhrt-2018-000901. eCollection 2018.
- Hussain AI, Auensen A, Brunborg C, Beitnes JO, Gullestad L, Pettersen KI. Age-dependent morbidity and mortality outcomes after surgical aortic valve replacement. Interact Cardiovasc Thorac Surg. 2018 Nov 1;27(5):650-656. doi: 10.1093/icvts/ivy154.
- Auensen A, Hussain AI, Garratt AM, Gullestad LL, Pettersen KI. Patient-reported outcomes after referral for possible valve replacement in patients with severe aortic stenosis. Eur J Cardiothorac Surg. 2018 Jan 1;53(1):129-135. doi: 10.1093/ejcts/ezx228.
- Hussain AI, Garratt AM, Brunborg C, Aakhus S, Gullestad L, Pettersen KI. Eliciting Patient Risk Willingness in Clinical Consultations as a Means of Improving Decision-Making of Aortic Valve Replacement. J Am Heart Assoc. 2016 Mar 18;5(3):e002828. doi: 10.1161/JAHA.115.002828.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2010
Primary Completion (Anticipated)
April 1, 2014
Study Completion (Anticipated)
June 1, 2014
Study Registration Dates
First Submitted
February 16, 2013
First Submitted That Met QC Criteria
February 19, 2013
First Posted (Estimate)
February 20, 2013
Study Record Updates
Last Update Posted (Estimate)
April 3, 2014
Last Update Submitted That Met QC Criteria
April 2, 2014
Last Verified
April 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SAS
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Stenosis
-
National Institute of Cardiology, Warsaw, PolandThe Institute of Bioorganic Chemistry, Polish Academy of SciencesRecruitingAortic Stenosis | Low-gradient Aortic StenosisPoland
-
MiRusRecruitingAortic Stenosis | Symptomatic Severe Native Aortic StenosisUnited States
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
Edwards LifesciencesCompletedAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Azienda Ospedaliera "Sant'Andrea"University of Bologna; Politecnico di Milano; Centro Cardiologico Monzino; I.R.C...RecruitingAortic Stenosis | Calcific Aortic Valve Disease | Chronic Coronary Syndrome | Calcific Aortic StenosisItaly
-
Hospices Civils de LyonCompleted
-
Edwards LifesciencesRecruitingAortic Valve Stenosis | Aortic Stenosis, CalcificUnited States, Australia, Switzerland, Canada, Japan, Netherlands
-
Abbott Medical DevicesCompletedSevere Aortic Stenosis | Symptomatic Degenerative Aortic StenosisSpain, Italy, United Kingdom, Germany, Switzerland, Czechia, Australia, Belgium, Poland
-
University of AlbertaNot yet recruitingAortic Stenosis | Severe Aortic StenosisCanada
-
Medtronic CardiovascularCompleted